Author  
Place of duty  
Title   진행성 식도암에 대한 5-FU 및 Cisplatin ( FP ) 복합화학요법 ( 5-Fluorouracil and Cisplatin ( FP ) Combination Chemotherapy in Advanced Esophageal Cancer )
Publicationinfo   1996 Jan; 028(05): 835-842.
Key_word   Esophagus, Squamous cell carcinoma, 5-fluorouracil, Cisplatin
Full-Text  
Abstract   Esophageal Carcinoma is widely disseminated in many patients at the time of diagnosis. Therefore systemic chemotherapy has assumed an important role in the treatment of this disease. We conducted a phase II trial of 5-fluorouracil and cisplatin in 39 patients with advanced esophageal cancer. The regimen consisted of 5-fluorouracil, 1,000 mg/§³/day in 12 hour continuous infusion on day 1 to 5 and cisplatin, 60 mg/§³/day iv on day 1 every three weeks. Response rates were calculated only from 37 patients with measurable disease. The response rate was 39%(complete response 2%, partial response 37%) with a median duration of 4 months (range 2~10 months). Median time of survival for all patients was 9 months(range 1~4 months). The toxicities were moderate. This study demonstrates that combination of 5-fluoriuracil and cisplatin is an efficient and tolerable chemotherapy regimen in patients with advanced esophageal cancer.
저 자   우인숙(In Sook Woo),정경해(Kyung Hae Jung),박영이(Young Iee Park),이정애(Jung Ae Rhee),허대석(Dae Seog Heo),방영주(Yung Jue Bang),김노경(Noe Kyeong Kim)